Summary. Cystine aminopeptidase and arylamidase activities in human serum were determined by enzymic hydrolysis of l-cystine-di-\g=b\-naphthylamide(CysNA) and l \ x=r eq-\ leucine-\g=b\-naphthylamide(LeuNA), respectively. 
Introduction
During pregnancy an aminopeptidase that is able to inactivate oxytocin and vasopressin appears in the maternal serum (von Fekete, 1930; Stoklaska & Wintersberger, 1959) . The enzyme, originally named oxytocinase, disappears rapidly after parturition and has been suggested to play an important role in the maintenance and termination of a normal pregnancy (Gazarek et al, 1976) . However, the physiological importance of serum oxytocinase has been questioned because oxytocin is rapidly removed from the circulation by the liver and kidneys.
Oxytocinase and cystine aminopeptidase (EC 3.4.11.3) are considered to be the same enzyme (Tuppy & Nesvadba, 1957; Melander, 1965) . Cystine aminopeptidase levels show a progressive rise throughout normal pregnancy, reaching a maximum in the last trimester (Babuna & Yenen, 1966; Gazarek et al, 1976) . The enzyme is present in high concentration in the placental tissue (Lampelo & Vanha-Perttula, 1979) and the cystine aminopeptidase (oxytocinase) activity determined in the serum of pregnant women with oxytocin or various synthetic substrates (among these L-cystine-di-ß-naphthylamide and L-leucine-ß-naphthylamide) may be of placental origin (Oya, Yoshino, Mizutani & Wakabayashi, 1974) . The enzyme con¬ centration in maternal serum is supposed to reflect the increased activity of the placental tissue (Spellacy, Usategui-Gomez & Fernandez-deCastro, 1977) .
Normal serum contains several aminopeptidases (Kulling & Yman, 1970) . The activity of an arylamidase which hydrolyses L-leucine-ß-naphthylamide has been known to increase during pregnancy and has been considered to be at least partly due to the appearance of cystine amino¬ peptidase (oxytocinase), which shows a broad substrate specificity (Kulling & Yman, 1970 ).
This report is concerned with the fractionation of sera from pregnant and non-pregnant women by gel filtration and the biochemical characterization of the enzyme activities with lcystine-di-ß-naphthylamide and L-leucine-ß-naphthylamide as substrates.
Materials and Methods

Blood samples
Maternal blood samples were taken from the brachial vein at 38-41 weeks of pregnancy. The women were healthy and had no complications of pregnancy and in each case there was normal fetal growth. Serum samples from non-pregnant women were used as controls. The women had not used any oral contraceptives. The sera were separated after clotting by centrifugation at 600 g for 10 min, at+4°C.
Reagents
All reagents were obtained as indicated by Lampelo & Vanha-Perttula (1979) .
Gelfiltration
Gel filtration by Sepharose 6B was carried out as described earlier (Lampelo & VanhaPerttula, 1979) . The gel bed was equilibrated and the serum samples of 5 ml were eluted with 0-02 M-Tris-HCl buffer, pH 7-0. The buffer contained 0-15 M-NaCl. Fractions of 10 ml were collected at +4°C.
Measurement of the enzyme activity
The hydrolysis of L-cystine-di-ß-naphthylamide (CysNA) and L-leucine-ß-naphthylamide (LeuNA) was determined as described by Lampelo & Vanha-Perttula (1979) . The incubation medium contained 0-3 ml 0-1 M-Tris-HCl buffer, pH 7-0 (unless otherwise indicated), 0-1 ml enzyme solution and 0-1 ml substrate solution at a final concentration of 0-25 mM. After incu¬ bation at 37°C the liberated ß-naphthylamine was coupled with 0-2 ml of Fast Garnet GBC in 1 M-acetate buffer, pH 4-2, to which 10% Tween was added to disperse the colour product. The absorbancies were read spectrophotometrically at a wavelength of 525 nm. The aminopeptidase activities of total sera (unfractionated sera) are given as µ ß-naphthylamine liberated/min/mg protein. All the assays were in duplicate or triplicate and in the studies of enzyme characteristics a duplicate control from the same sample was always included. The protein concentrations of total serum samples were estimated according to Lowry, Rosebrough, Farr & Randall (1951 
Discussion
In this study fractionation of human maternal serum by gel filtration showed that pregnancy caused the appearance of a new enzyme, which has cystine aminopeptidase (cystine amino¬ peptidase Im) and arylamidase (arylamidase Im) activity. The activities appeared to be identical with those previously characterized from human placenta (Lampelo & Vanha-Perttula, 1979 ). This supports the previous conclusion that maternal serum cystine aminopeptidase (oxyto¬ cinase) is of placental origin (Oya et al, 1974; Small & Watkins, 1975) . The present study also showed that serum from non-pregnant women contains two aminopeptidases one of which hydrolysed L-leucine-ß-naphthylamide (LeuNA) and weakly L-cystine-di-ß-naphthylamide (CysNA) and the other only CysNA. Goebelsmann & Beller (1965) isolated by Sephadex G-200 gel filtration one arylamidase from control serum, and another enzyme, which was poorly separated from control serum arylamidase, from maternal serum. They reported that control serum arylamidase hydrolysed LeuNA 75 times faster than CysNA, and maternal serum cystine aminopeptidase was shown to hydrolyse LeuNA 11 times faster than CysNA. Goebelsmann & Beller (1965) concluded that weak cystine aminopeptidase activity in control serum is due to arylamidase activity. Cystine aminopeptidase II, isolated from maternal and control serum in the present study, has not previously been detected.
Serum cystine aminopeptidase (oxytocinase) activities, measured by a bioassay, are approxi¬ mately 13 times higher in pregnant than in non-pregnant women while arylamidase activities at term are 3-5 times higher (Tuppy & Nesvadba, 1957; Goebelsmann & Beller, 1965) . Goebelsmann & Beller (1965) suggested that the 3-5-fold increase in arylamidase activity is due to the appearance of cystine aminopeptidase, and the broad substrate specificity of the amino¬ peptidase produces pseudo-cystine aminopeptidase values in control serum. We found that both cystine aminopeptidase and arylamidase activities increased markedly during pregnancy, but the increase was higher with CysNA (12-5-fold) than with LeuNA (8-3-fold).
Ryden (1966) and Christensen (1974) determined the pH optimum for unfractionated control and maternal serum cystine aminopeptidase (oxytocinase). They used CysNA as sub¬ strate and demonstrated that the pH optimum increased during pregnancy. We found that the pH optima for maternal serum enzyme preparation I were higher than those for arylamidase Ic.
Cystine aminopeptidase II had the same pH optimum in maternal and control serum. It is possible that the previously observed increase in pH optimum of cystine aminopeptidase is due to the new maternal serum enzyme(s) appearing only during pregnancy.
EDTA inhibits maternal serum cystine aminopeptidase (oxytocinase) (Werle & Semm, 1956; Ryden, 1966) and control serum arylamidase (Fleisher, Pankow & Warmka, 1964; McDonald, Reilly & Ellis, 1964 (Melander, 1965) has not yet been confirmed.
Many investigators (Tuppy & Wintersberger, 1960; Werle & Semm, 1956; Mäkinen & Raekallio, 1974) have studied the effect of divalent metal ions on maternal serum cystine amino¬ peptidase (oxytocinase) activity and observed activation, inhibition or no response in the enzyme activity. In the present study, maternal and control serum Enzymes I were more sensitive to Ni2+ than was cystine aminopeptidase II, whereas Zn2+ was inhibitory to all of these enzyme activities. Even (1956) and Vanha-Perttula, Hopsu & Glenner (1966) , who have shown that an ion-determined specificity explains the different response obtained in the hydrolysis of the various amino acid naphthylamide substrates by a single aminopeptidase. Tiderström & Heinegàrd (1978) have studied the hydrolysis of L-cystine-bis-4-nitroanilide, lcystine-di-ß-naphthylamide and S-benzyl-L-cysteine-4-nitroanilide by unfractionated pregnant serum cystine aminopeptidase. They showed that Co2+ activated the hydrolysis but the activation level was different with each of the substrates. Tiderström & Heinegàrd (1978) suggested that the differences in the response to Co2+ were caused by the chemical and steric properties of each substrate used and were probably not due to different enzymes.
Cystine aminopeptidase II was resistant to EDTA, and its activity was not altered by di¬ valent metal ions after EDTA treatment. However, the rate of hydrolysis by this enzyme was also decreased after EDTA treatment at low molarities of phosphate buffer. It has earlier been shown that serum cystine aminopeptidase activity during liver diseases is higher in Tris than in phosphate buffer (Tiderström & Heinegàrd, 1978) , while normal serum arylamidase activity is decreased (Fleisher et al, 1964) . Because it is possible that serum aminopeptidases prefer different buffers and the buffer used influences enzyme characteristics, the buffer dependence should be taken into consideration in the characterization and quantitation of serum amino¬ peptidase activities.
Fleisher et al (1964) showed that L-methionine inhibits competitively the control serum arylamidase. Oya et al (1974) showed electrophoretically that the enzyme in control serum was inhibited by L-methionine (0-02 m), whereas maternal serum enzyme bands (CAP15 CAP2), representing two conformational forms of a single enzyme, were resistant to the treatment. This differential response has subsequently been suggested as being useful for estimating specifically the possible placental aminopeptidase activity in maternal serum (Mizutani, Yoshino & Oya, 1976 In the present work cystine aminopeptidase Im and arylamidase Im had higher molecular weights (309 000) than control serum arylamidase (130 000). Yman & Sjöholm (1967) estimated the molecular weight of oxytocinase purified from retroplacental serum as 325 000 and Yman (1970) obtained a value of 290 000. Oya, Yoshino & Mizutani (1975) (Lampelo & Vanha-Perttula, 1979) , and this enzyme appears to be distinct from any of the previously characterized serum aminopeptidases. Since maternal and control sera contain this cystine aminopeptidase activity which hydrolyses CysNA, a synthetic substrate for oxytocinase, further studies are necessary to explore its tissue origin and physiological function in serum. It should also be taken into consideration during development of a specific method for oxytocinase for monitoring the placental functions.
